Valuation : Medpace Holdings, Inc.

Market Cap 16.5B 14.19B 13.35B 12.19B 22.79B 1,561B 22.86B 158B 61.18B 799B 61.98B 60.62B 2,546B P/E 2026 *
33.6x
P/E 2027 * 30.9x
Enterprise Value 15.7B 13.5B 12.7B 11.59B 21.68B 1,485B 21.75B 151B 58.21B 760B 58.97B 57.68B 2,422B EV / Sales 2026 *
5.51x
EV / Sales 2027 * 5.04x
Free-Float
80.34%
Yield 2026 *
-
Yield 2027 * -
1 day-0.35%
1 week-1.56%
Current month-0.45%
1 month+1.07%
3 months+30.17%
6 months+25.65%
Current year+5.28%
1 week 581.78
Extreme 581.78
599.25
1 month 571.01
Extreme 571.01
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
27/08/26 Sell

Chief Executive Officer

-650 0.0023%
26/08/26 Exercice

Director

11,574 0.0415%
26/08/26 Sell

Chief Executive Officer

-4,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%-1.56%+21.42%+120.75% 16.5B
-1.16%-3.97%-2.91%+13.00% 48.93B
-0.40%+1.03%+418.57%+527.30% 45.01B
-1.42%+2.30%+42.67%+22.37% 44.07B
-1.22%-2.31%+4.82%+77.49% 40.73B
-0.96%-2.31%+15.75%+45.41% 33.52B
-0.21%+9.14% - - 17.77B
-1.54%-1.05%+12.16%+29.80% 14.67B
-1.65%-1.03%+75.93%+41.12% 13.77B
+0.78%-3.04%-5.74%-35.78% 12.72B
Average -0.78%+0.13%+64.74%+93.50% 28.77B
Weighted average by Cap. -0.87%-0.08%+84.50%+120.69%

Financials

2026 *2027 *
Net sales 2.85B 2.45B 2.31B 2.11B 3.94B 270B 3.95B 27.35B 10.57B 138B 10.71B 10.48B 440B 3.03B 2.6B 2.45B 2.24B 4.18B 286B 4.19B 29.03B 11.22B 147B 11.37B 11.12B 467B
Net income 503M 432M 406M 371M 694M 47.53B 696M 4.82B 1.86B 24.34B 1.89B 1.85B 77.53B 547M 470M 442M 404M 755M 51.69B 757M 5.24B 2.03B 26.47B 2.05B 2.01B 84.32B
Net Debt -802M -690M -649M -592M -1.11B -75.88B -1.11B -7.69B -2.97B -38.86B -3.01B -2.95B -124B -1.25B -1.08B -1.01B -925M -1.73B -118B -1.73B -12.01B -4.64B -60.64B -4.7B -4.6B -193B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
04/09/26 $591.29 -0.35% 146,430
03/09/26 $593.39 +0.06% 143,232
02/09/26 $593.02 +1.68% 204,197
01/09/26 $583.21 -1.81% 179,867
31/08/26 $593.99 -1.11% 347,286
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
591.29USD
Average target price
581.83USD
Spread / Average Target
-1.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!